Clinical Trial

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

Study acronym: FOSTIK
Completed
View on ClinicalTrials.gov →
Summary
Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-05
notable Enrollment increased: 180 -> 360 participants 2026-08-05
notable Primary completion pushed: 2026-05 -> 2026-08-03 2026-08-05
minor Completion moved earlier: 2027-05 -> 2026-08-03 2026-08-05
Trial Details
NCT Number NCT03071536
Lead Sponsor King Chulalongkorn Memorial Hospital
Conditions Kidney Function, Kidney Transplant; Complications, Delayed Graft Function
Enrollment 360 participants
Start Date 2016-11-25
Primary Completion 2026-08-03 (estimated)
Study Completion 2026-08-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-04